Nanobiotix S.A. (NBTX)

NASDAQ: NBTX · IEX Real-Time Price · USD

7.23

-0.02 (-0.28%)

May 17, 2024, 12:00 AM EDT - Market open

Nanobiotix Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	36.21	4.78	2.65	2.51	2.54	Upgrade
Revenue Growth (YoY)	658.10%	80.43%	5.37%	-1.14%	-26.96%	Upgrade
Gross Profit	36.21	4.78	2.65	2.51	2.54	Upgrade
Selling, General & Admin	22.05	17.86	19.43	14.61	18.91	Upgrade
Research & Development	38.4	32.64	30.38	24.33	30.41	Upgrade
Other Operating Expenses	2.54	0.99	5.41	0	0	Upgrade
Operating Expenses	62.99	51.48	55.23	38.94	49.32	Upgrade
Operating Income	-26.78	-46.7	-52.58	-36.43	-46.78	Upgrade
Interest Expense / Income	14.8	13.86	0.78	-2.65	4.97	Upgrade
Other Expense / Income	-2	-3.53	-6.36	-0.2	-0.84	Upgrade
Pretax Income	-39.58	-57.03	-47	-33.58	-50.91	Upgrade
Income Tax	0.12	0.01	0.01	0.01	0	Upgrade
Net Income	-39.7	-57.04	-47	-33.59	-50.92	Upgrade
Shares Outstanding (Basic)	35	35	35	33	33	Upgrade
Shares Change	1.02%	0.14%	7.03%	-	-	Upgrade
EPS (Basic)	-1.08	-1.64	-1.35	-1.38	-2.35	Upgrade
EPS (Diluted)	-1.08	-1.64	-1.35	-1.38	-2.35	Upgrade
Free Cash Flow	-12.81	-37.2	-30.11	-27.65	-42.61	Upgrade
Free Cash Flow Per Share	-0.36	-1.07	-0.86	-0.85	-1.31	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-73.96%	-977.85%	-1986.36%	-1450.20%	-1840.97%	Upgrade
Profit Margin	-109.65%	-1194.33%	-1775.71%	-1337.18%	-2003.74%	Upgrade
Free Cash Flow Margin	-35.39%	-778.81%	-1137.33%	-1100.52%	-1677.02%	Upgrade
EBITDA	-23.26	-41.67	-44.66	-34.47	-44.18	Upgrade
EBITDA Margin	-64.25%	-872.45%	-1687.12%	-1372.33%	-1738.49%	Upgrade
Depreciation & Amortization	1.51	1.5	1.56	1.75	1.77	Upgrade
EBIT	-24.78	-43.17	-46.22	-36.23	-45.94	Upgrade
EBIT Margin	-68.43%	-903.85%	-1746.05%	-1442.16%	-1808.03%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).